Location: Home
  • search
  • go
  • Relate News
  • 10/3/2025Medilink Initiates U.S. Phase 1/2 Trial for VEGF-Targeted ADC YL242
  • 10/3/2025Santen and RemeGen Files Chinese BLA for RC28-E
  • 10/1/2025China Rolls Out 2025 Pharmacopoeia to Sharpen Drug Oversight
  • 9/30/2025China's Biopharma Sector Sees Surge in IPO Activity on HKEX and SSE
  • 9/30/2025China Issues Detailed Rules on Pre-Approval Import of Overseas Drugs
  • 9/30/2025Chinese Drugmakers Face Mounting Risks From Washington Despite Tariff ...
  • 9/29/2025Novatim Strikes Licensing Deal for Dual-Target CAR-T Therapy as China ...
  • 9/29/2025China Eliminates 30% Import Duty on Indian Drugs Amid Global Trade Shi...
  • 9/26/2025China's Innovative Drug Market Shows Diverging Trends Between Hospital...
  • 9/26/2025Recent Official and Executive Moves
  • 9/25/2025SystImmune to Unveil New Clinical Data on Two ADC Programs at ESMO 202...
  • 9/24/2025Hengrui's ADC SHR-A181 Lands $1.1B Licensing Deal with Glenmark
  • 9/24/2025NMPA Accepts Alphamab's NDA for HER2 BsAb in Gastric Cancer
  • 9/23/2025KeyMed Initiates First Phase 3 Trial for CD3/BCMA BsAb CM336
  • 9/23/2025MicuRx Plans Private Placement to Raise Up to ¥1B
  • 9/23/2025Innovent's Weight-Loss Drug Challenges Western Giants in China's Obesi...
  • 9/23/2025China Unveils New Rules for 11th Round of National Centralized Drug VB...
  • 9/23/2025CMS and Generix Join Forces for Innovative Biologics
  • 9/23/2025China's Edge over U.S. Biotech Was Never Scientific (Washington Post)
  • 9/22/2025Marengo Launches Combined Phase II Trial of Invika and Trodelvy in Met...
  • 9/22/2025MagicRNA Publishes First-in-Human Data for In Vivo CAR-T Therapy in SL...
  • 9/22/2025Ascletis' ASC47 Combined with Semaglutide Shows Superior Weight Loss a...
  • 9/20/2025Ascletis and Sagimet's Acne Drug Demonstrates Rapid Efficacy in Chines...
  • 9/20/2025Recent Executive Moves
  • 9/19/2025Novartis Vows Greater Commitment to China Amid Innovation Surge
  • 9/19/2025GE HealthCare Explores Selling Stake in China Unit Amid Market Pressur...
  • 9/19/2025Lilly/Innovent's Mazdutide Approved in China for Type 2 Diabetes Glyce...
  • 9/19/2025​​​​​​​China Biopharma at Crossroads: A Mid-2025 Tale of Contra...
  • 9/18/2025Strengthening Oversight of Imported Drugs: Key Takeaways into New Regu...
  • 9/17/2025Two Chinese Biotechs File for IPOs in Hong Kong as Losses Mount but Pi...
  • Page:3/370 Total number of articles:11087: [First][<<] [1] [2] [3] [4] [5] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group